Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova

Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova

The early availability of effective vaccines against SARS-CoV-2, the aetiologic cause of COVID-19, has been at the cornerstone of the global recovery from the pandemic. This study aimed to assess the antispike RBD IgG antibody titres and neutralisation potential of COVID-19 convalescent plasma and t...

Full description

Bibliographic Details
Main Authors: Mariana Ulinici, Alen Suljič, Monica Poggianella, Rafaela Milan Bonotto, Katarina Resman Rus, Angela Paraschiv, Amedeo Marco Bonetti, Mihail Todiras, Alexandru Corlateanu, Stanislav Groppa, Emil Ceban, Miroslav Petrovec, Alessandro Marcello
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Vaccines
Subjects:
SARS-CoV-2
vaccine
Sinopharm
BBIBP-CorV
RBD ELISA
neutralisation assay
Online Access:https://www.mdpi.com/2076-393X/11/3/637

Internet

https://www.mdpi.com/2076-393X/11/3/637

Similar Items